|
|||||
|
|
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies |
|
| Abstract: | |
| Keywords: | glucocorticoid receptor selective GR activator (SEGRA) lymphoma leukemia multiple myeloma proteasome inhibitor |